TORONTO (August 20, 2018) – The Canadian Association of Psoriasis Patients (CAPP) today launched a digital media campaign that highlights the barriers to treatment for Canadian psoriasis patients.
Leading up to the release of the 2018 CAPP Psoriasis Report Card: Access to Care and Treatment for Patients in Canada in October, the newly launched website PSOSerious.ca will educate Canadians about the health and lifestyle impact of psoriasis, invite patients and caregivers to share their stories, and provide an opportunity to connect with their elected officials to advocate for better access to treatment.
Psorisasis impacts an estimated one million Canadians, the majority of which are not on treatment or optimal treatment. The chronic skin condition is associated with an increased risk of developing other chronic systemic diseases, including heart attack and stroke, diabetes, cancer and liver disease. Up to 60 per cent of people with psoriasis—regardless of severity—may develop depression. Still, patients must wait an average of 15 weeks for access to dermatological care.
“In order to thrive, psoriasis patients need access to dermatologists, phototherapy, and a range of treatment options,” said Kathryn Andrews-Clay, CAPP’s executive director. “The last time we conducted this research in 2014, Canada scored “needs improvement” on access to dermatological care, and “fail” in access to phototherapy and medications. The research we are undertaking for the 2018 report card will show what the progress has been.”
Canadians are invited to make their voices heard on this important issue by visiting PSOSerious.ca.